Results 251 to 260 of about 508,157 (387)

Prognostic impact of p16 and high‐risk HPV DNA in ~1300 patients with vulvar cancer

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Vulvar cancer (VSCC) is rare, and little is known about early prognostic factors that could contribute to an individualized treatment plan. About 30%–40% of VSCCs are associated with human papillomavirus (HPV). Here, the authors investigated the prognostic influence of p16 status in VSCC in a large cohort of 1300 patients.
Susanne K. Kjær   +14 more
wiley   +1 more source

A promising frontier of circulating messenger RNA in liquid biopsy: From mechanisms to clinical applications

open access: yesInternational Journal of Cancer, EarlyView.
Abstract Liquid biopsy can revolutionize cancer patient management as repeated sampling allows real‐time monitoring of disease progression and response to treatment. The circulating transcriptome represents a rich source of potential cancer biomarkers, including coding and non‐coding RNAs.
Mengqian Li   +7 more
wiley   +1 more source

Snapshot of Obstetric National Audit and Research Project (SONAR1): aprotocol for an international observational cohort study. [PDF]

open access: yesBMJ Open
Patel R   +13 more
europepmc   +1 more source

Preeclampsia and risk of breast cancer: A longitudinal cohort study of tumor histology

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Preeclampsia is protective against breast cancer, but it is not clear if the effect extends to all breast tumors. This study examined the association between preeclampsia and breast tumor histology. The findings suggest that the protective effect of preeclampsia is concentrated among ductal and lobular tumors, but not other tumors. Patients
Shu Qin Wei   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy